Messenger RNA for Two Type IV Collagenases is Located in Stromal Cells in Human Colon Cancer

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 1993 Feb 1

PMID 8434636

Citations 71

Authors

C Pyke

E Ralfkiaer

K Tryggvason

K Dano

Affiliations

Soon will be listed here.

Abstract

The gene expression of two type IV collagen-degrading enzymes (72-kd and 92-kd type IV collagenases) was investigated in human colon adenocarcinomas by in situ hybridization. In all cases (18 out of 18), messenger RNA for the 72-kd type IV collagenase was present and located in numerous fibroblasts in the stroma surrounding the invasive cancer tissue. In normal-appearing colonic mucosa distant from the cancer tissue, either no expression or only very weak expression of this enzyme was detected. Also the 92-kd type IV collagenase was found in all samples investigated (10 out of 10), exclusively expressed by tissue macrophages. A very strong hybridization signal for messenger RNA for the 92-kd enzyme was found in a subpopulation of tissue macrophages surrounding invading malignant epithelium. In normal-appearing colon tissue, a markedly weaker hybridization signal was observed in macrophages contained in Peyer's patches. No hybridization signals for either of the two type IV collagenases were detected in cancer cells. Together with previous findings on expression of components of the plasminogen activation system, these results indicate that several nonepithelial cell types in the tumor stroma are involved in production of factors involved in extracellular proteolysis during colon cancer invasion.

Citing Articles

Relationship between metalloproteinase-9 (MMP-9) expression and clinicopathology in colorectal cancer: a cross-sectional study.

Mudatsir , Labeda I, Uwuratuw J, Hendarto J, Warsinggih , Lusikooy R Ann Med Surg (Lond). 2023; 85(9):4277-4282.

PMID: 37663709 PMC: 10473300. DOI: 10.1097/MS9.0000000000000892.

Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage.

Hingorani D, Lippert C, Crisp J, Savariar E, Hasselmann J, Kuo C PLoS One. 2018; 13(9):e0198464.

PMID: 30248101 PMC: 6152858. DOI: 10.1371/journal.pone.0198464.

Investigation of malignant transformation of sporadic adenomas of colon by fluorimetry.

Korneva Y, Dorosevich A, Maryakhina V Lasers Med Sci. 2016; 32(2):363-367.

PMID: 27942988 DOI: 10.1007/s10103-016-2125-2.

Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.

Illemann M, Lovendahl Eefsen R, Bird N, Majeed A, Osterlind K, Laerum O Mol Carcinog. 2015; 55(2):193-208.

PMID: 25594187 PMC: 6680289. DOI: 10.1002/mc.22269.

The effect of imiquimod on matrix metalloproteinases and tissue inhibitors of metalloproteinases in malignant melanoma cell invasion.

Jung J, Kim H, Roh M, Roh H, Lee S, Chung K Ann Dermatol. 2014; 26(3):363-73.

PMID: 24966637 PMC: 4069648. DOI: 10.5021/ad.2014.26.3.363.

References

Edwards D, Murphy G, Reynolds J, Whitham S, Docherty A, Angel P . Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987; 6(7):1899-904. PMC: 553574. DOI: 10.1002/j.1460-2075.1987.tb02449.x. View

Murphy G, WARD R, Gavrilovic J, Atkinson S . Physiological mechanisms for metalloproteinase activation. Matrix Suppl. 1992; 1:224-30. View

Collier I, Wilhelm S, Eisen A, Marmer B, Grant G, Seltzer J . H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem. 1988; 263(14):6579-87. View

Wilhelm S, Collier I, Marmer B, Eisen A, Grant G, Goldberg G . SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 1989; 264(29):17213-21. View

Huhtala P, Eddy R, Fan Y, Byers M, Shows T, Tryggvason K . Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. Genomics. 1990; 6(3):554-9. DOI: 10.1016/0888-7543(90)90486-e. View

Liotta L, Tryggvason K, Garbisa S, Robey P, Abe S . Partial purification and characterization of a neutral protease which cleaves type IV collagen. Biochemistry. 1981; 20(1):100-4. DOI: 10.1021/bi00504a017. View

Hibbs M, Hasty K, Seyer J, Kang A, Mainardi C . Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem. 1985; 260(4):2493-500. View

Dano K, Andreasen P, Kristensen P, Nielsen L, Skriver L . Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985; 44:139-266. DOI: 10.1016/s0065-230x(08)60028-7. View

Lund L, Riccio A, Andreasen P, Nielsen L, Kristensen P, Laiho M . Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J. 1987; 6(5):1281-6. PMC: 553930. DOI: 10.1002/j.1460-2075.1987.tb02365.x. View

10.

Fearon E, Vogelstein B . A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5):759-67. DOI: 10.1016/0092-8674(90)90186-i. View

11.

Huhtala P, Chow L, Tryggvason K . Structure of the human type IV collagenase gene. J Biol Chem. 1990; 265(19):11077-82. View

12.

Stetler-Stevenson W, Brown P, Onisto M, Levy A, Liotta L . Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem. 1990; 265(23):13933-8. View

13.

Basset P, Bellocq J, Wolf C, Stoll I, Hutin P, Limacher J . A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990; 348(6303):699-704. DOI: 10.1038/348699a0. View

14.

Ralfkiaer E, Kirkeby L, Kristensen P, Lund L, Dano K . Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol. 1991; 138(1):111-7. PMC: 1886060. View

15.

Bishop J . Molecular themes in oncogenesis. Cell. 1991; 64(2):235-48. DOI: 10.1016/0092-8674(91)90636-d. View

16.

Liotta L, Steeg P, Stetler-Stevenson W . Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991; 64(2):327-36. DOI: 10.1016/0092-8674(91)90642-c. View

17.

Lotz M, Guerne P . Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem. 1991; 266(4):2017-20. View

18.

Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Blasi F, Dano K . Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol. 1991; 138(5):1059-67. PMC: 1886028. View

19.

Nathan C, Sporn M . Cytokines in context. J Cell Biol. 1991; 113(5):981-6. PMC: 2289009. DOI: 10.1083/jcb.113.5.981. View

20.

Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Dano K . The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res. 1991; 51(15):4067-71. View